UnitedHealth’s stock has plummeted in recent months. It is now one of the S&P 500 Index’s worst performers. The stock price has plummeted from a high of 620 dollars to $247. The market cap has dropped from $575 billion at the high to $295 billion.
UnitedHealth Stock Price Crash: Why?
UnitedHealth is facing a lot of criticism this year due to its slowing growth. UNH continues to struggle, according to the most recent figures.
The company’s revenues reached $109.6 Billion, an increase of $9.8 Billion from the previous year. This was due to a growth in its client base. The company saw a 780,000 increase in its customer base from the previous year.
The stock fell after the company reduced its guidance.
According to the company’s updated guidance, its adjusted earnings per share will range from $26.50 to 26.50. Wall Street analysts predict its EPS to be $22.15 in this year. This is a significant decrease from last year’s total of $27.66. In 2026, its EPS will be around $26.
This slowdown can be attributed to the difficulties with Medicare Advantage, a service that it currently leads. MA is an approved service by Medicare that’s offered by private firms. This is a service offered by private companies that has been approved by Medicare. It bundles together hospital insurance, medicare and prescription drug coverage.
UnitedHealth’s stock is cheap historically, but you shouldn’t purchase it before July 29. Here’s why.
The Biden Administration changed the prices that the company could charge. The medicare cost was on the rise, and this has led to a reduction in its profit margins.
The UnitedHealth share price dropped because Optum’s technology enabled health services were having problems. Optum operates Optum Health, OptumRx, and OptumInsight. UNH, as an insurance company, is hard hit when healthcare costs increase.
UnitedHealth’s Change Healthcare, a service that collects data from over 190,000,000 customers, was also hacked. Six terabytes worth of confidential data were stolen.
Analysts and investors therefore place their hope in Stephen Hemsley as the new CEO, who is expected to bring back business growth to its historic trajectory between 13% to 16%.
UNH’s stock is viewed by analysts in a variety of ways. Baird analysts have downgraded the rating of outperform from neutral to underperform. UBS analysts have given a positive rating. They have assigned a Buy rating. JPMorgan Piper Sandler and Barclays also have rated an Overweight rating.
UNH Stock Price Technical Analysis
UnitedHealth’s share price is clearly visible on the weekly chart. It has dropped dramatically in recent months. The 50-week Exponential moving averages (EMA) and the 200-week EMA have recently crossed. This has formed a Death Cross pattern. The death cross pattern is considered to be one of the more bearish ones.
UnitedHealth’s stock price formed a popular bearish flag, which is a continuation signal. The stock price also moved under the bottom of the rising-channel pattern.
The stock is likely to continue dropping as the sellers aim for the critical support level of $246, which was the lowest point this week.
You can read more about how insiders bought UnitedHealth shares during the recent crash. Should you do the same?
The UnitedHealth post stock price shows two distinct patterns that may change as the updates are released.
